{
    "clinical_study": {
        "@rank": "112488", 
        "brief_summary": {
            "textblock": "Understanding the clinical practice of treatment of cardiac rhythm disorders all over the\n      world and understanding the clinical outcomes of the treatment with its cardiac rhythm\n      products in real world patient population is essential for Medtronic to be able to\n      effectively develop new products and adjust existing products. In addition Medtronic is\n      committed to monitor the safety of its products throughout the entire life cycle to ensure\n      maximum product reliability.\n\n      The Panorama 2 registry will enable Medtronic to increase data collection of clinical\n      practice with Medtronic implantable Cardiac Rhythm and Disease Management (CRDM) devices in\n      various regions across the world and on product reliability of its CRDM devices."
        }, 
        "brief_title": "PANORAMA 2 Observational Study", 
        "completion_date": {
            "#text": "July 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Rhythm Disorders", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  Patient is 18 years of age or older (lower age limit dependent on local law: to be\n             specified in country-specific addendum to the clinical investigational plan, if\n             applicable)\n\n          -  Patient or Legally Authorized Representative provides signed and dated authorization\n             and/or consent per institution and local requirements\n\n          -  Patient will be treated with a commercially available implantable Medtronic CRDM\n             device/ Vitatron device within maximally 30 days after enrollment or within 3 days\n             prior to enrollment\n\n        Exclusion criterion:\n\n        \u2022 Patient has exclusion criteria per local law (to be specified in country-specific\n        addendum to the clinical investigational plan, if applicable)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "All patients that have a Medtronic implantable CRDM Device implanted (including Vitatron),\n        which is commercially available at the start of the registry or becomes commercially\n        available during the course of the registry, and used within its intended use, may be\n        included.\n\n        These products are:\n\n          -  Pacemaker systems: Implantable Pulse Generators (IPG) and cardiac leads\n\n          -  Defibrillation systems: Implantable Cardioverter Defibrillators (ICD) and cardiac\n             leads\n\n          -  Resynchronization systems: Cardiac Resynchronization Therapy (CRT):\n\n               -  Cardiac Resynchronization Therapy - Pacemaker (CRT-P) and cardiac leads\n\n               -  Cardiac Resynchronization Therapy - Defibrillator (CRT-D) and cardiac leads\n\n          -  Implantable Loop Recorders (ILR)"
            }
        }, 
        "enrollment": {
            "#text": "8500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 6, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01723566", 
            "org_study_id": "PANORAMA 2"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "November 28, 2013", 
        "location": {
            "contact": {
                "email": "amirabdelwahab@gmail.com", 
                "last_name": "Abdelwahhab"
            }, 
            "facility": {
                "address": {
                    "city": "Cairo", 
                    "country": "Egypt"
                }, 
                "name": "Cairo University Hospital"
            }, 
            "investigator": {
                "last_name": "Amir Abdelwahab, Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Egypt"
        }, 
        "number_of_groups": "1", 
        "official_title": "Panorama 2 Medtronic CRDM Implantable Cardiac Device Long Term Registry", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "NA: No oversight authorities involved", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2019", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To describe the region-specific current clinical practices associated with the device treatment of patients receiving implantable Medtronic CRDM devices by collecting information on the patient characteristics (demographics, medical history and cardiovascular status), the type of Medtronic CRDM devices used, the indication for the use of the Medtronic CRDM devices and the clinical outcomes of the treatment with the Medtronic CRDM devices (all deaths, cardiovascular hospitalizations, Serious Adverse Device Effects and NYHA class).", 
            "measure": "Describe region-specific clinical practice of CRDM device use", 
            "safety_issue": "Yes", 
            "time_frame": "2012-2019"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01723566"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Medtronic Bakken Research Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Bakken Research Center", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "November 2013"
    }
}